Gene ID | Gene Name ▲ | Gene Symbol | Disease Ontology |
---|---|---|---|
105155041 | glycogen [starch] synthase |
|
|
105151786 | glycoprotein 3-alpha-L-fucosyltransferase A |
|
|
105153414 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like |
|
|
105145765 | glycosyltransferase 25 family member-like |
|
|
105151389 | glycosyltransferase-like protein LARGE2 |
|
|
105143423 | heparan sulfate 6-O-sulfotransferase |
|
|
105145297 | hyaluronan synthase-like protein kkv |
|
|
105145775 | lactosylceramide 4-alpha-galactosyltransferase-like |
|
|
105145634 | mannose-P-dolichol utilization defect 1 protein homolog |
|
|
105143860 | phosphatidylinositol glycan anchor biosynthesis class A |
|
|
105146668 | phosphatidylinositol glycan anchor biosynthesis class B |
|
|
105152573 | phosphatidylinositol glycan anchor biosynthesis class V |
|
|
105149381 | phosphatidylinositol glycan anchor biosynthesis class Z |
|
|
105150450 | polypeptide N-acetylgalactosaminyltransferase 2 |
|
|
105149939 | polypeptide N-acetylgalactosaminyltransferase 35A |
|
|
105146221 | polypeptide N-acetylgalactosaminyltransferase 5 |
|
|
105151261 | polypeptide N-acetylgalactosaminyltransferase 9 |
|
|
105148687 | probable C-mannosyltransferase DPY19L1 |
|
|
105151528 | probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase |
|
|
105145883 | probable dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase |
|
|
105154554 | putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase |
|
|
105154658 | serine/arginine repetitive matrix protein 1-like |
|
|
105149042 | transmembrane and TPR repeat-containing protein 1-like |
|
|
105147655 | transmembrane and TPR repeat-containing protein CG4050-like |
|
|
105154781 | uncharacterized LOC105154781 |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024